info@seagull-health.com
SeagullHealth
语言:
search

Eltrombopag(Revolade)

Names
艾曲波帕,瑞弗兰
Indicatons
Used to treat thrombocytopenia in patients with immune thrombocytopenia (ITP), chronic hepatitis C, or severe aplastic...
Price:
Manufacturer:
Novartis
Dosage form:
TABLET
Validity period:
24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Revolade(Eltrombopag) Instructions:Uses,Dosage, Side Effects

PROMACTA (eltrombopag) is an oral medication that works by activating the thrombopoietin receptor, leading to increased platelet production. It is available in tablet and oral suspension forms. 

The drug is metabolized extensively and has specific pharmacokinetic properties that require careful dosing adjustments in certain populations, such as those with hepatic impairment or East-Southeast-Asian ancestry. It is designed to help manage low platelet counts in various medical conditions, with a focus on reducing bleeding risks.

Generic name
Eltrombopag(Revolade)
English name
Eltrombopag
Alternative Names
艾曲波帕,瑞弗兰
Drug prices
Indications

Treatment of thrombocytopenia in adults and pediatric patients (≥1 year) with persistent or chronic ITP who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.

Treatment of thrombocytopenia in patients with chronic hepatitis C to enable initiation and maintenance of interferon-based therapy.

First-line treatment of severe aplastic anemia in combination with immunosuppressive therapy (IST) in adults and pediatric patients (≥2 years).

Treatment of severe aplastic anemia in patients with an insufficient response to immunosuppressive therapy.

Therapeutic Target
Thrombopoietin (TPO) receptor
Active Ingredients
Eltrombopag
Dosage Form
TABLET
Specifications
25mg * 28 tablets/box
Dosage and Administration

Administer orally once daily on an empty stomach or with a low-calcium meal (≤50 mg calcium). Avoid concurrent use with polyvalent cation-containing products (e.g., antacids, dairy) within 2 hours before or 4 hours after dosing.

Dosing is individualized based on indication, age, hepatic function, and ethnicity (e.g., reduced initial doses for East/Southeast Asian patients or those with hepatic impairment).

Monitor platelet counts regularly and adjust dose to achieve target platelet levels (e.g., ≥50×10⁹/L for ITP). Maximum daily doses: 75 mg (ITP), 100 mg (hepatitis C), 150 mg (SAA).

Oral suspension must be reconstituted with water and administered immediately (within 30 minutes).

    Recommended articles
    Related articles
    Contraindications and adverse reactions of itraconazole
    Although eltrombopag has no absolute contraindications, it has clear warnings and potential serious adverse reactions. Understanding these risks is a prerequisite for safe medication use.I. Contraindi...
    Special population medication of eltrombopag
    The use of eltrombopag in special populations requires individualized adjustment. This article reviews key medication points around factors such as hepatic and renal function, age, and ethnicity.I. Do...
    Precautions for healthy diet of patients with eltrombopag
    When taking eltrombopag, diet directly affects drug absorption and efficacy. Mastering the correct dietary principles is an important part of ensuring safe and effective treatment.I. Timing of Medicat...
    Dosage, Administration, Precautions, and Healthy Lifestyle Recommendations for Eltrombopag (Revolade)
    Eltrombopag is a prescription medication. Proper use directly impacts its efficacy and safety.1. Dosage and Administration1.1 Immune Thrombocytopenia (ITP)(1) Adults and children aged 6 years and olde...
    A Complete Analysis of the Price, Medical Insurance Coverage and Efficacy of Eltrombopag (Revolade)
    Eltrombopag is a targeted drug used to increase platelet count. Patients are most concerned about its price, medical insurance reimbursement, and actual therapeutic effects.I. Is Eltrombopag Covered b...
    How Effective Is Eltrombopag (Revolade) in Treatment?
    Eltrombopag (Revolade) is an oral thrombopoietin receptor agonist that plays an important role in the treatment of various hematological diseases.How Effective Is Eltrombopag (Revolade) in Treatment?E...
    New Drugs
    Cenobamate(Xcopri)
    Cenobamate(Xcopri)
    It is used for the treatment of partial-onset seizures in adults (with or...
    Infigratinib(Truseltiq)
    Infigratinib(Truseltiq)
    Treatment of previously treated, unresectable locally advanced or metastatic...
    Opicapone(Ongentys)
    Opicapone(Ongentys)
    Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
    Deflazacort(Emflaza)
    Deflazacort(Emflaza)
    Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
    Counselling Service
    Global Drug Search
    Clinical Research Recruitment
    Overseas Medical Treatment
    Remote Consultations
    Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
    Submit
    Business
    • Core products
    • Antitumor drugs
    • General drug
    • Antiviral drugs
    • Biological agents
    Contact Us 
    • haiousales@gmail.com
    Welcome to consult
    Seagull Pharmacy.,Ltd All rights reserved